ARTICLE | Finance
City is location of Maraganore’s next RNAi play
BioCentury’s latest Venture Report includes rounds for Judo, Purespring, Basecamp, Arda and more
October 11, 2024 1:22 AM UTC
John Maraganore is getting back into RNAi, but this time as executive chair of newco City.
With $135 million raised in a series A round, the co-founder and former CEO of RNAi leader Alnylam Inc. (NASDAQ:ALNY) is looking to build the next generation of siRNA molecules at Cambridge, Mass.-based City Therapeutics Inc. The round was led by Arch Venture Partners, where Maraganore is also a venture partner...